Canara Bank Securities Ltd

Similar documents
Ujjivan Financial Services Ltd Banking/Finance. BUY Rating as per Midcap 12 Months investment period RETAIL EQUITY RESEARCH

Canara Bank Securities Ltd

FY17 FY18 FY19E FY20E

South Indian Bank Buy

Ujjivan Financial Services Ltd Banking/Finance BUY RETAIL EQUITY RESEARCH

Indostar Capital Finance

Ujjivan Financial Services Ltd Banking/Finance. Buy RETAIL EQUITY RESEARCH

Ujjivan Financial Services Ltd Banking/Finance BUY RETAIL EQUITY RESEARCH

Federal Bank BUY RETAIL EQUITY RESEARCH

FY17 FY18 FY19E FY20E

Ujjivan Financial Services Ltd Banking/Finance. Accumulate RETAIL EQUITY RESEARCH

DCB Bank Ltd. 18 th August, 2014 BUY

CMP: Stock Data Sector. Stock Performance (%) Shareholding Pattern (%) Sensex and stock movement. 6 th March, 2017

Federal Bank Ltd. Banking/Finance. Accumulate RETAIL EQUITY RESEARCH

City Union Bank BUY. 24 February 2016 INR82

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset

Ujjivan Financial Services Ltd.

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Aster DM Healthcare Limited

Buy Rating as per Mid Cap 12months investment period

(INR Crores) FY16 FY17 FY18 FY19E FY20E. Net interest income 15, , , , , Growth% -8% -2% 0% 26% 6%

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

FY17 FY18 FY19E FY20E

Investor Presentation Q2 FY November 2017

Punjab National Bank

Can Fin Homes BUY. 23 September 2015 INR821

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

Fineotex Chemical Ltd

HOLD. Buyback of Old Mutual s stake in K-Life KOTAK MAHINDRA BANK. Target Price: Rs 965

Karnataka Bank. Rating: BUY. Bank - Private. Short Note. Brief Financials

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

Manappuram Finance (MGFL IN) Healthy operating performance

Industry: Finance Reco: Subscribe Date: March 09, 2018

BUY Rating as per Largecap 12months investment period

Tata Elxsi Ltd. CMP: Rs. 1,192 Future Stallion.. BUY. Stock Data. Stock Performance (%) Company Update IT Software India Research

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

HOLD Rating as per Large Cap 12 month investment period

Reliance Capital (RELCAP) 549

Change EPS. (Rs) FY

Reliance Housing Finance

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Bajaj Finserv (BAFINS) 5443

State Bank of India (STABAN) 335

Hold Target Price: Rs 574

Shriram Transport Finance

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability

IndusInd Bank (INDBA) 1717

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

M&M Financial Services (MMFSL)

Punjab National Bank

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

DCB Bank. Strong performance, valuation comforting

Muthoot Capital Services Ltd Q2 FY18 Result Analysis

RBL Bank BUY. CMP Target Price `573 `690. Quick take BANK. January 7, year price chart

Union Bank of India (UNIBAN)

Bajaj Finance (BAJAF) 5498

Capital First Ltd. NBFC. Buy RETAIL EQUITY RESEARCH

Equitas Holdings Limited Investor Presentation Q1FY19 Quarter ended 30 June 2018

I Direct. nstinct. November 27, 2017

CanFin Homes. Turning over a new leaf CMP: Rs134. Reco: Buy

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

BUY. Structural changes in the making CAPITAL FIRST. Target Price: Rs 920. Key drivers

State Bank of India (SBI)

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Reliance Capital (RELCAP)

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Bank of Baroda (BANBAR) 156

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

PNB Housing Finance Ltd. Robust play in Indian HFC sector SUBSCRIBE 24th Oct, 2016

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

Havells India. Q1FY18 Result Update Strong Sales growth; Margins decline. Sector: Consumer Durable CMP: ` 467. Recommendation: BUY

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

NIIT Technologies Ltd. 15 th February, 2016 BUY

Punjab National Bank

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

BUY. Q4 hurt by MFI business EQUITAS HOLDINGS. Target Price: Rs 190

HOLD KOTAK MAHINDRA BANK LTD. Highlights. STANDALONE Result Update: Q3 FY14. CMP Target Price JAN. 29 th, 2014

Punjab National Bank

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Bajaj Finserv (BAFINS) 3130

LKP Bytes. Lakshmi Vilas Bank Outperformer. April 10, Q3 Financial Performance. Industry: Banking

Industry: Banking Recommendation: Subscribe Date: August 12, 2016

Karur Vysya Bank (KVB) KVB IN; KVB.BO

Bank of Baroda (BOB)

BUY RETAIL EQUITY RESEARCH. HDFC Ltd. NBFC. Better placed among housing finance companies (HFCs) GEOJIT BNP PARIBAS Research

Graphite India Ltd. Hold. Margins dip due to weak realizations; maintain hold INDIA. Metals

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

AXIS BANK PRICE: RS.1422 TARGET PRICE: RS.1535 FY14E P/E: 10.0X, P/ABV: 1.9X

R-Power Suzlon. JSW Energy NHPC

Transcription:

A WHOLLY OWNED SUBSIDIARY OF CANARA BANK Stock update UJJIVAN FINANCIAL SERVICES LTD CMP : 373 (26.02.2018,BSE) PRICE TARGET : 425 STOCK DETAILS Industry BFSI Market Cap(Rs Bn) 45.04 52 Week High/Low 465/285 Face Value (Rs) 10 Number of Shares (Cr.) 12.06 About the Company Incorporated in 2005, Ujjivan Financial Services Ltd (UFSL) is a largest Indian microfinance services NBFC in terms of geographical spread, primarily based on the joint liability group lending model for providing collateral free small ticket-size loans to economically active poor. UFSL loan products include agricultural, education, livestock loans, home improvement, MSE and home purchase. In addition to loan products they also provide non-credit offerings comprising of life insurance products in partnership with insurance providers such as Bajaj Allianz Life Insurance, Kotak Mahindra Life Insurance and HDFC Life Insurance Company Ltd. Ujjivan Financial operations are spread across 22 states and 2 union territories and 209 districts across India. UFSL serve over 3.71 million active borrowers through 421 branches and 10,881 employees. Ujjivan received the small finance bank (SFB) license from the Reserve Bank of India on 11th November 2016 and commenced its banking operations in February 2017. SFBs are permitted to collect low cost deposits to cater the credit requirements of the underserved. STOCK PERFORMANCE (%) Stock BSE 500 1 Month (5.44) (4.90) 3 Months (10.10) 0.80 6 Months 18.67 7.70 1 Year (13.92) 21.30 SHARE HOLDING PATTERN Q3FY18 RESULT UPDATE Ujjivan Financial Services Ltd. (UFSL) is back on track after demonetization initial hiccups. The collection efficiency improved to 99.70% for all the new business given after Jan 17 till now. This has cleared the clamors surrounded on the micro finance institutions after structural reforms such as demonetization and GST to systematize the informal unorganized economy. Being the prominent unorganized and underserved financers, the NBFCs and also Small Finance Banks have faced difficult times due to mounting NPAs and increased provisions accordingly. UFSL management prudent decisions made early recognition of NPAs and higher provisions in the first 2 quarters of FY18. However subsequent dedicated recovery teams along with write offs of bad loans brought the Gross NPA to 4.24 in Q3FY18 from peak of 6.16% in Q1FY18. The Net NPA also brought down to 1.04% levels in Q3FY18 from peak of 2.30% in Q1FY18. The financial institution total write offs in this year moved to Rs.132 crores including 34 crores during this quarter. This has helped UFSL to improve the Provision coverage ratio to 76.30%. The full-fledged SFB branch conversion is also on track. Total 121 branches got converted to full-fledged SFBs. UFSL planning to convert total 188 by year end. The conversion of branches had increased the cost-to-income substantially to 69.05% in Q3FY18 from 49.33% in Q3FY17. But these all are one time measures and helpful in attracting larger cliental base with improved low cost deposits. Over all UFSL is back on track and going ahead we are expecting good traction in both advances and deposit.

Performance for Q3FY18 Steady growth of Loan book: UFSL Net Loan book increased to Rs.6926.66 core with 14.57% YoY and 8.83% QoQ growth. The robust growth in MSE and Affordable housing has contributed significantly to the overall loan book. The MSE and Affordable Housing business share of total portfolio increased to 5.5% in Q3FY18 from 4.3% in previous quarter. Being a small finance bank, Overdraft kind of new facilities were made available to MSE borrowers, which were not available to NBFCs. Disbursement steadily increased to Rs.2134.32 crores in Q3FY18 with 28.35% YoY growth. Moreover, the cashless disbursement percentage increased to 64.51% in Q3FY18 from 30.83% in Q3FY17. This is the positive sign to address hitherto operational mismanagements of unorganized borrowers. Asset quality improvement: UFSL asset quality improved significantly in this quarter as guided by the management. The GNPA and NNPA reduced to 4.24% and 1.04% in Q3FY18 against 4.99% and 1.38% in Q2FY18. Total R.131.71 crore write off have been made in this year, which resulted in improving Provision Coverage Ratio to 76.30% from 73.40% IN Q2FY18. The dedicated collection team to focus on 90 days plus bucket of overdue loans had given positive result in containing the bad debts. The management claims that newly formed recovery verticals have made 34% of recoveries in this quarter. Thus, resulted in reducing PAR>90 days loans to 5.4% in Q3FY18 from 6.7% in Q2FY18. Stellar growth in low cost Deposits and decline in cost of Funds: UFSL deposits had surged to 2437 crores in Q3FY18 with 80.60% QoQ growth. UFSL largely benefited by Small Finance Bank transformation with reduced average cost of funds to 9.3% in Q3FY18 from 10.4% in FY17. Deposits constitute 36% of Advances in Q3FY18 against 22% in Q2FY18 and Deposits contribute 35% to total funding in Q3-FY18, an increase from 20% in Q2-FY18. UFSL had made prepayment of Rs.2255 crores high cost legacy loans including 950 crores in this fiscal year. Average cost of funds raised during Q3FY18 was 7%, which was much lower than total average cost of funds. Hence, UFSL Net Interest Margin improved to 11.08% in Q3FY18 from 10.20% in Q2FY18. UFSL is commanding A1+ rating from CRISIL, ICRA, and A+ (Stable) from CARE.

Borrowing Profile (Rs. in Cr.) Q3FY18 Q2FY18 Term Loans from Banks/NBFC 1,740 2,670 Refinance Facility 1695 1,440 Securitization / IBPC (Off Balance Sheet) 169 305 Non-Convertible Debentures 600 625 Short term borrowings 400 385 Deposits 2436 1349 Total Outstanding Amount 7041 6774 Adequate Capital requirements: UFSL is having adequate capital cusion with 22.05% in Q3FY18. RBI recent directives exempted Small Finance Banks from capital charge on market and operational risk weights. This will help in reducing risk weighted capital for SFBs and provide more leverage to advances. As per RBI guidelines SFBs should maintain 15% CAR with 7.5% Tier-1. Profitability back on Track: Improving asset quality and reduction of provisions brought down credit cost from 5.7% in Q2FY18 to 1.7% in Q3FY18, which resulted in bringing Net Profit to Rs.29.32 crores from loss of Rs.11.95 crores in Q2FY18. The ROA and ROE turned to be positive 1.35% and 6.99% respectively in Q3FY18 from -0.56% and -2.86% in Q2FY18. However the cost to income ratio had increased to 69.05% in Q3FY18 marginally high from 68.82% in Q2FY18 due to branch conversion and other expansion overheads. Going ahead the management is expecting good traction from the revamped branches as the full fledged branches are expected to attract new customer base with low cost CASA and deposits. SIL and ICRA.

Key Financial Data Profit and Loss Statement (Rs. Cr.) Q3FY18 Q3FY17 YoY % Q2FY18 QoQ% 9MFY18 9MFY17 YoY % Revenue from operations 358.06 362.18 (1.14) 339.27 5.54 1020.73 1034.84 (1.36) Other income 26.07 9.14 185.26 38.75 (32.73) 100.06 22.79 339.1 Total Income 384.13 371.32 3.45 378.03 1.61 1120.79 1057.63 5.97 Finance costs 141.35 133.19 6.13 152.97 (7.59) 451.58 381.03 18.52 Employee expenses 93.22 70.72 31.82 89.53 4.13 270.68 195.07 38.76 Provisions and write offs 28.69 54.75 (47.59) 88.19 (67.46) 276.1 67.95 (306.35) Total Expenses 337.47 304.92 10.67 396.04 (14.79) 1206.81 770.49 56.63 Profit before Tax(PBT) 46.66 66.39 (29.73) -18.02 358.94 (86.02) 287.13 (129.96) Tax Expenses 17.34 22.45 (22.78) -6.07 385.78 (28.45) 98.81 (128.79) Profit after Tax 29.32 43.94 (33.28) -11.95 345.31 (57.58) 188.32 (130.57) KEY RATIOS GNPA 294.3 15.12 1846 323.29 (8.09) - - - GNPA % 4.24 0.25 399 bps 4.99 75 bps - - - NNPA % 1.04 0.05 99 bps 1.38 34 bps - - - ROA 1.35 2.53 118 bps (0.56) 191 bps (0.88) 3.88 476 bps ROE 6.99 10.28 329 bps (2.86) 885 bps (4.45) 17.14 2159 bps Balance Sheet (Rs. Cr.) Q3FY18 Q3FY17 YoY % Q2FY18 QoQ % Share capital 120.61 118.84 1.48 119.74 0.72 Reserves and surplus 1573 1614.02 (2.54) 1540.25 2.13 Borrowings 4435.41 5150.69 (13.89) 5119.73 (13.37) Deposits 2335.43 - - 1247.53 87.2 Provisions 292.46 168.52 73.55 298.81 (2.13) Other Liabilities 161.51 171.42 (5.78) 154.12 4.8 Total 8918.41 7223.49 23.46 8480.17 5.17 Cash and cash equivalent 433.04 830.21 (47.84) 349.1 24.05 Advances 6926.66 6102.11 13.51 6364.39 8.83 Investments 0.1 0.1-0.1 - Fixed & tangible assets 183.91 107.25 71.48 171.93 6.96 Other assets 1374.7 183.82 647.84 1594.65 (13.79) Total 8918.41 7223.49 23.46 8480.17 5.17

Valuation Considering the past performance, present economic conditions, prudential corporate governance measures and the management guidance; we expect the company to post a reasonable top line growth rate of ~22% in FY19E. The company currently trades at ~2.40 P/B and forward P/B works out to 2.19 P/B for FY19E; We continue to maintain our positive outlook on the stock. Investors may buy the stock on dips and accumulate for a price target of Rs.425. Particulars (Rs. in Cr.) FY16 FY17 FY18E FY19E Total Income 1027.61 1397.62 1396.69 1703.96 Net Interest Income 507.50 687.41 814.36 1001.66 Net Profit 177.22 207.67 (22.39) 153.60 Gross NPA (%) 0.28 0.30 3.82 3.56 Net NPA (%) 0.04 0.03 0.94 0.76 Book value per share (Rs.) 118.37 147.03 148.53 169.78 EPS 16.20 17.76 (1.86) 12.74 ROA% 3.65 2.92 (0.28) 1.56 ROE% 18.32 14.07 (0.69) 7.96 P/E 19.80 19.90-29.27 P/B 2.90 2.40 2.40 2.19 (Source: Company Presentation, Ace Equity)

Disclosures and Disclaimers CANARA BANK SECURITIES LTD (CBSL), a wholly owned subsidiary of CANARA BANK, is a SEBI registered intermediary offering broking services to its institutional and retail clients; we also run a proprietary trading desk. CBSL is member of BSE & NSE. Neither CBSL nor its associates (i) have any financial interest in the company which is the subject matter of this research report (ii) holds ownership of one percent or more in the securities of subject company (iii) have any material conflict of interest at the time of publication of the report (iv) have received any compensation from the subject company in the past twelve months (v) have received any compensation for investment banking merchant banking or brokerage services from the subject company in the past twelve months (vi) have received any compensation for product or services from the subject company in the past twelve months (vii) have received any compensation or other benefits from the subject company or third party in connection with the research report. (viii) Research Analyst involved in the preparation of Research report discloses that he /she has not served as an officer, director, or employee of subject company( ix) is involved in market making activity of the company. We shall adhere to SEBI guidelines from time to time. We may have earlier issued or may issue in future reports on the companies covered herein with recommendations/ information inconsistent or different those made in this report. We may rely on information barriers, such as "Chinese Walls" to control the flow of information contained in one or more areas within us, or other areas, units, groups or affiliates of CBSL. The Research Desk does not solicit any action based on the material contained herein. It is for the general information of the clients / prospective clients of CBSL. CBSL will not treat recipients as clients by virtue of their receiving the research report. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of clients / prospective clients. Similarly, the Research Desk does not have regard to the specific investment objectives, financial situation/circumstances and the particular needs of any specific person who may receive it. The securities discussed in the report may not be suitable for all investors. The appropriateness of a particular investment or strategy will depend on an investor's individual circumstances and objectives. Persons who may receive the research report should consider and independently evaluate whether it is suitable for his/ her/their particular circumstances and, if necessary, seek professional/financial advice. And such person shall be responsible for conducting his/her/their own investigation and analysis of the information contained or referred to in the research report and of evaluating the merits and risks involved in the securities forming the subject matter of the reports. All projections and forecasts in research reports have been prepared by our research team. The client should not regard the inclusion of the projections and forecasts described herein as a representation or warranty by CBSL For these reasons; The client should only consider the projections and forecasts described in the research reports after carefully evaluating all of the information in the report, including the assumptions underlying such projections and forecasts. Past performance is not a guide for future performance. Future returns are not guaranteed and a loss of original capital may occur. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. We do not provide tax advice to our clients, and all investors are strongly advised to consult regarding any potential investment. CBSL or its research team involved in the preparation of the research reports, accept no liabilities for any loss or damage of any kind arising out of the use of these reports. The technical levels and trend etc mentioned in our reports are purely based on some technical charts/levels plotted by software used by us and these charts/levels are believed to be reliable. No representation or warranty, express or implied is made that it is accurate or complete. The recommendation expressed in the reports may be subject to change. The recommendations or information contained herein do/does not constitute or purport to constitute investment advice in publicly accessible media and should not be reproduced, transmitted or published by the recipient. This research reports are for the use and consumption of the recipient only. This publication may not be distributed to the public used by the public media without the express written consent of CBSL. The Research reports or any portion hereof may not be printed, sold or distributed without the written consent of CBSL. The research report is strictly confidential and is being furnished to client solely for client s information, may not be distributed to the press or other media and may not be reproduced or redistributed to any other person. The opinions and projections expressed herein are entirely based on certain assumptions & calculations and are given as part of the normal research activity of CBSL and are given as of this date and may be subject to change. Any opinion estimate or projection herein constitutes a view as of the date of this report and there can be no assurance that future results or events will be consistent with any such opinions, estimate or projection. The report has not been prepared by or in conjunction with or on behalf of or at the instigation of, or by arrangement with the company or any of its directors or any other person. Any opinions and projections contained herein are entirely based on certain assumptions and calculations. None of the directors of the company or any other persons in the research team accepts any liability whatsoever for any loss arising from any use of the research report or its contents or otherwise arising in connection therewith. The information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized reading, dissemination, distribution or copying of this communication is prohibited unless otherwise expressly authorized. Please ensure that the client has read Risk Disclosure Document for Capital Market and Derivatives Segments as prescribed by Securities and Exchange Board of India (SEBI) before investing in Securities Market. Please remember that investment in stock market is subject to market risk and investors/traders need to do study before taking any position in the market. Research Desk SEBI: RESEARCH ANALYST REGISTRATION: INH000001253 BSE: INB 011280238, BSE F&O: INF 011280238 NSE: INB 23180232, F&O: INF 231280232, CDS: 231280232 Maker Chambers III, 7th floor, Nariman Point, Mumbai 400021 Contact No. : 1800220369/18001031369, 022-22802441/42, 43603841/42 Email id: researchdesk@canmoney.in Website: www.canmoney.in